Targeted Fatty-Acid Glycerol Ester Compounds for Localized Cavitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for improved bubble-forming compounds and methods for their use in minimally invasive medical treatments, particularly for conditions characterized by the presence of obstructions or abnormal masses such as kidney stones, urinary stones, biliary stones, blood clots, fibroids, and atheromatous plaques, as existing technologies are inadequate in effectively targeting and treating these conditions without damaging healthy tissue.
Innovation Solution
The development of fatty-acid glycerol ester derivative compounds that form microbubbles capable of cavitation upon application of energy, which selectively bind to metal-containing bodies like calcium-containing plaques, allowing for targeted treatment of conditions by inducing cavitation to break down these obstructions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional shock wave therapy is used to treat kidney stones and other obstructions, then the therapeutic effect is achieved through cavitation, but healthy tissue is damaged in the process
Solution Approach 1:
The microbubbles are functionalized with targeting ligands (antibodies, peptides, or small molecules) that specifically bind to receptors on the surface of pathological tissues such as kidney stones, tumors, or atherosclerotic plaques. This ensures that the cavitation effect is localized only to the target site where the microbubbles accumulate, while surrounding healthy tissue remains unaffected. The selective binding is achieved through receptor-ligand interactions that are specific to the pathological condition being treated.
Solution Approach 2:
The microbubbles serve as intermediaries that carry targeting ligands to the pathological site. These microbubbles are composed of a gas core surrounded by a shell that can be functionalized with various targeting moieties. The microbubbles accumulate at the target site through passive perfusion or active targeting mechanisms, and then serve as the site for localized cavitation when exposed to ultrasound, thereby mediating the therapeutic effect while protecting healthy tissue.
2Object-affected harmful factors
If minimally invasive treatments are used to reduce pain and discomfort, then patient comfort is improved, but the ability to effectively destroy abnormal masses is reduced
Solution Approach 1:
The treatment employs periodic pulsed ultrasound waves to induce cavitation in the accumulated microbubbles. The ultrasound is delivered in controlled pulses rather than continuous waves, allowing for precise control of the cavitation intensity and duration. This periodic action enables effective destruction of abnormal masses while limiting the total energy exposure to healthy tissues, thereby maintaining the minimally invasive nature of the treatment.
Solution Approach 2:
The microbubbles undergo phase transitions during cavitation, transitioning from a stable gaseous state to a collapsed state when exposed to ultrasound. This phase transition releases concentrated mechanical energy at the microbubble site, creating localized high-pressure shock waves that can effectively fragment or destroy abnormal masses such as kidney stones or tumors, while the overall treatment remains minimally invasive.
3Adaptability or versatility
If non-specific cavitation is used to treat obstructions, then treatment coverage is broad, but selectivity for target tissue is lost
Solution Approach 1:
The microbubbles are functionalized with specific targeting ligands that confer local quality to the treatment. Different ligands can be used to target different pathological conditions (e.g., anti-VCAM for atherosclerosis, RGD peptides for tumors), allowing the same microbubble platform to be adapted to various conditions while maintaining high targeting accuracy. This modular approach preserves both versatility and selectivity.
Solution Approach 2:
The microbubble platform serves as a universal carrier that can be functionalized with various targeting ligands to treat different pathological conditions. The basic microbubble structure and cavitation mechanism remain the same, providing universal applicability, while the specific ligand attached determines the target specificity. This multi-functionality allows a single platform to address multiple conditions including kidney stones, tumors, atherosclerosis, and other obstructions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively treat conditions like kidney stones and atheromatous plaques by binding to calcium-containing materials and inducing cavitation, providing a minimally invasive method that reduces tissue damage and enhances treatment efficacy.
Implementation Method 1
microbubbles capable of cavitation upon application of energy, which selectively bind to metal-containing bodies like calcium-containing plaques, allowing for targeted treatment of conditions by inducing cavitation to break down these obstructions
Data Source
Figure 1A
Figure 1B
Figure 2A~2B
AI summary
The present disclosure is directed to fatty-acid glycerol ester derivative compounds containing a targeting bisphosphonate group. The disclosure further include pharmaceutical or biomedical compositions comprising these compounds, and methods of using these compounds and compositions forming microbubbles. The microbubbles have affinity for metal-containing, especially calcium-containing, bodies and/or biological targets. In certain embodiments, these compositions are useful for providing targeted placement of microbubbles capable of cavitation on application of high frequency energy.